The abstract is read at the publisher; the summary is JClub's.
Loss of core microRNA machinery components AGO2 or ANKRD52 in tumor cells makes them hypersensitive to NK-cell killing, with mitochondrial collapse and TNF-α–linked apoptosis in co-culture and xenografts.
- Why it matters: Tumor-intrinsic resistance limits NK-cell immunotherapy efficacy, but the mitochondrial and apoptotic vulnerabilities created by defective miRNA silencing in tumors were unclear.
- What they did: Tumor cells with genetic ablation of Ago2 or Ankrd52 were tested in co-culture and xenograft models; miRNA silencing of mitochondrial apoptotic regulators (including Bim repression by miR-24 and miR-29b) was assessed alongside mitochondrial membrane potential, ATP, and ultrastructure.
- The result: Mutant tumor cells showed collapsed membrane potential, diminished ATP, fragmented mitochondria, and a lower apoptotic threshold upon TNF-α or NK challenge; genome-wide CRISPR screening revealed selective fitness dependency on mitochondrial electron-transport and ATP synthase genes, nominating miRNA-pathway status as a predictive biomarker.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.